Characteristics of bronchial asthma with persistent airflow limitation

D. Rai, Shiv Kumar, A. Ranjan, R. Kirti
{"title":"Characteristics of bronchial asthma with persistent airflow limitation","authors":"D. Rai, Shiv Kumar, A. Ranjan, R. Kirti","doi":"10.4103/ijaai.ijaai_35_18","DOIUrl":null,"url":null,"abstract":"BACKGROUND: Asthma is a chronic inflammatory disorder of airway characterized by variable symptoms and variable airflow limitation. There are many patients developed persistent airflow limitation in due course of disease due to many factors. The present study was conducted to characterize this phenotype and to identify the factors which are implicated in causing persistent airflow limitation. MATERIALS AND METHODS: We recruited consecutive 164 patients aged <40 years (to exclude chronic obstructive pulmonary disease [COPD]), diagnosed, and treated as bronchial asthma in our asthma clinic for at least 6 months. We took all clinical, lung function detail and compared between asthma with or without persistent airflow limitation. The patients were assigned to the group with persistent airflow obstruction if they presented postbronchodilator forced expiratory volume in 1 s (FEV1) or FEV1/forced vital capacity values <70% predicted. RESULTS: A total of 114 patients included in the study and 42 (36.84%) patients had persistent airflow limitation. The patients with persistent airflow limitation have a higher age and more proportion of patients were male. History of allergic rhinitis is an important risk factor found associated with asthma with persistent airflow limitation (P≤ 0.001). 26.19% of patients with persistent airflow limitation had a history of symptom since childhood and generally having a longer disease duration compared to patient without airflow limitation (P < nonsignificant). Reversibility criteria (>12% and >200 ml increase in FEV1) was fulfilled by only 26.7% of the study patients. The factors such as onset of disease after 18 years, history of atopy, serum IgE level, family history of asthma, and biomass fuel exposure did not differ between groups with or without airflow limitation. CONCLUSIONS: Bronchial asthma is more having a COPD such as spirometry features if it has been started since childhood, longer disease duration, and history of allergic rhinitis. Reversibility in spirometry, which is specific for asthma diagnosis, is found only in one-fourth of the patients.","PeriodicalId":53075,"journal":{"name":"Indian Journal of Allergy Asthma and Immunology","volume":"113 1","pages":"51 - 55"},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Allergy Asthma and Immunology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ijaai.ijaai_35_18","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

BACKGROUND: Asthma is a chronic inflammatory disorder of airway characterized by variable symptoms and variable airflow limitation. There are many patients developed persistent airflow limitation in due course of disease due to many factors. The present study was conducted to characterize this phenotype and to identify the factors which are implicated in causing persistent airflow limitation. MATERIALS AND METHODS: We recruited consecutive 164 patients aged <40 years (to exclude chronic obstructive pulmonary disease [COPD]), diagnosed, and treated as bronchial asthma in our asthma clinic for at least 6 months. We took all clinical, lung function detail and compared between asthma with or without persistent airflow limitation. The patients were assigned to the group with persistent airflow obstruction if they presented postbronchodilator forced expiratory volume in 1 s (FEV1) or FEV1/forced vital capacity values <70% predicted. RESULTS: A total of 114 patients included in the study and 42 (36.84%) patients had persistent airflow limitation. The patients with persistent airflow limitation have a higher age and more proportion of patients were male. History of allergic rhinitis is an important risk factor found associated with asthma with persistent airflow limitation (P≤ 0.001). 26.19% of patients with persistent airflow limitation had a history of symptom since childhood and generally having a longer disease duration compared to patient without airflow limitation (P < nonsignificant). Reversibility criteria (>12% and >200 ml increase in FEV1) was fulfilled by only 26.7% of the study patients. The factors such as onset of disease after 18 years, history of atopy, serum IgE level, family history of asthma, and biomass fuel exposure did not differ between groups with or without airflow limitation. CONCLUSIONS: Bronchial asthma is more having a COPD such as spirometry features if it has been started since childhood, longer disease duration, and history of allergic rhinitis. Reversibility in spirometry, which is specific for asthma diagnosis, is found only in one-fourth of the patients.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
持续气流受限支气管哮喘的特点
背景:哮喘是一种以不同症状和不同气流限制为特征的气道慢性炎症性疾病。由于多种因素,许多患者在疾病的适当时期出现了持续的气流限制。本研究的目的是表征这种表型,并确定导致持续气流限制的因素。材料与方法:我们连续招募了164例年龄为12%的患者,只有26.7%的研究患者达到了200 ml的FEV1增加。18年后发病、特应性史、血清IgE水平、哮喘家族史和生物质燃料暴露等因素在有或没有气流限制的组之间没有差异。结论:如果支气管哮喘自儿童期开始、病程较长且有变应性鼻炎史,则支气管哮喘更具有COPD(如肺活量测定)特征。仅在四分之一的患者中发现了用于哮喘诊断的肺活量测定的可逆性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
22 weeks
期刊最新文献
Serum level of interleukin-6, interleukin-17A, and interferon-α in hospitalized COVID-19 patients and their clinical correlation: A hospital-based case–control study from North-East India Fungal sensitization and its impact on asthma control – A prospective study at allergy clinic Concurrent administration of COVID-19 vaccine and seasonal influenza vaccine: Expected rate of adverse effect Quality of life assessment in children and their caregivers suffering from allergic rhinitis and/or asthma Asthma management with the help of digital therapeutics: Review of clinical trials
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1